Literature DB >> 448152

Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defense.

J F Woodruff.   

Abstract

CD-1 mice inoculated with coxsackievirus B-3 i.p. developed a generalized infection involving the heart, pancreas, and liver. The disease was nonlethal and viral growth in the target organs was terminated in about a week. Administration of cortisone acetate 30 min to 2 hr before infection markedly enhanced the severity of disesae. Abnormally high titers of virus were found in the target organs between days 3 and 7 with persistence of infectious virus in the heart for at least 2 weeks. In addition the extent of necrosis of myofibers, pancreatic acini, and hepatic parenchyma was increased and a high percentage of the animals died. There was no evidence that the anti-viral antibody response was impaired in steroid-treated mice since concentrations of neutralizing antibody in the circulation were normal. In contrast, immigration of mononuclear inflammatory cells into the hearts of these animals was depressed and when present, foci of inflammation contained some polymorphonuclear leukocytes. The data indicate that inhibition of coxsackieviral growth cannot be attributed to the sole effects of neutralizing antibody and suggest that mononuclear inflammatory cells infiltrating the heart play a role in primary host defense.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448152

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

3.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.

Authors:  C Zaragoza; C Ocampo; M Saura; M Leppo; X Q Wei; R Quick; S Moncada; F Y Liew; C J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 5.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

6.  Coxsackievirus B infection in pregnant mice and transplacental infection of the fetus.

Authors:  J F Modlin; C S Crumpacker
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

Review 7.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

8.  Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors:  C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.

Authors:  R P Loudon; A F Moraska; S A Huber; P Schwimmbeck; P Schultheiss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Dietary hepatic cholesterol elevation: effects on coxsackievirus B infection and inflammation.

Authors:  A E Campbell; R M Loria; G E Madge; A M Kaplan
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.